A detailed history of Moore Capital Management, LP transactions in Eli Lilly & CO stock. As of the latest transaction made, Moore Capital Management, LP holds 29,000 shares of LLY stock, worth $26.3 Million. This represents 0.38% of its overall portfolio holdings.

Number of Shares
29,000
Previous 54,000 46.3%
Holding current value
$26.3 Million
Previous $31.5 Million 28.33%
% of portfolio
0.38%
Previous 0.58%

Shares

13 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2024

May 15, 2024

SELL
$592.2 - $792.28 $14.8 Million - $19.8 Million
-25,000 Reduced 46.3%
29,000 $22.6 Million
Q4 2023

Feb 14, 2024

BUY
$525.19 - $619.13 $28.4 Million - $33.4 Million
54,000 New
54,000 $31.5 Million
Q2 2023

Aug 14, 2023

BUY
$350.74 - $468.98 $7.79 Million - $10.4 Million
22,200 New
22,200 $10.4 Million
Q3 2022

Nov 14, 2022

BUY
$296.48 - $337.87 $2.87 Million - $3.27 Million
9,680 Added 12.05%
89,980 $29.1 Million
Q2 2022

Aug 15, 2022

BUY
$278.73 - $327.27 $22.4 Million - $26.3 Million
80,300 New
80,300 $26 Million
Q3 2021

Nov 15, 2021

SELL
$221.6 - $272.71 $7.43 Million - $9.15 Million
-33,545 Closed
0 $0
Q2 2021

Aug 16, 2021

BUY
$180.55 - $233.54 $6.06 Million - $7.83 Million
33,545 New
33,545 $7.7 Million
Q1 2020

May 15, 2020

SELL
$119.05 - $147.35 $9.9 Million - $12.3 Million
-83,162 Closed
0 $0
Q4 2019

Feb 14, 2020

BUY
$106.92 - $132.43 $8.89 Million - $11 Million
83,162 New
83,162 $10.9 Million
Q3 2019

Nov 14, 2019

SELL
$106.79 - $116.16 $6.75 Million - $7.34 Million
-63,176 Closed
0 $0
Q2 2019

Aug 14, 2019

SELL
$110.79 - $129.32 $1.96 Million - $2.29 Million
-17,729 Reduced 21.91%
63,176 $7 Million
Q1 2019

May 15, 2019

BUY
$111.31 - $131.02 $3.85 Million - $4.53 Million
34,546 Added 74.52%
80,905 $10.5 Million
Q4 2018

Feb 14, 2019

BUY
$105.9 - $118.64 $4.91 Million - $5.5 Million
46,359 New
46,359 $5.37 Million

Others Institutions Holding LLY

About ELI LILLY & Co


  • Ticker LLY
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 950,174,976
  • Market Cap $860B
  • Description
  • Eli Lilly and Company discovers, develops, and markets human pharmaceuticals worldwide. It offers Basaglar, Humalog, Humalog Mix 75/25, Humalog U-100, Humalog U-200, Humalog Mix 50/50, insulin lispro, insulin lispro protamine, insulin lispro mix 75/25, Humulin, Humulin 70/30, Humulin N, Humulin R, and Humulin U-500 for diabetes; and Jardiance, T...
More about LLY
Track This Portfolio

Track Moore Capital Management, LP Portfolio

Follow Moore Capital Management, LP and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Moore Capital Management, LP, based on Form 13F filings with the SEC.

News

Stay updated on Moore Capital Management, LP with notifications on news.